Substituted 5-chroman-5-yl-ethylamine compounds are disclosed. Also
disclosed are methods for the lowering and controlling of normal or
elevated intraocular pressure as well as a method for the treatment of
glaucoma using compositions containing one or more of the compounds of
the present invention.
